Press release —
Sigrid Therapeutics appoints Mattias Ankerberg, an international leader from the consumer goods industry, as Chairman
Stockholm, October 24, 2022. Sigrid Therapeutics, a Swedish consumer healthcare technology company, today announced that it has appointed Mattias Ankerberg as Chairman of the Board. Mattias has a long and successful career in the international retail and consumer goods industry. He is currently CEO of the listed Byggmax Group and a board member of Thule Group, and has previously worked for many years at H&M, most recently as Global Head of Sales & Marketing, and at McKinsey & Company, both in Sweden and the US. Sigrid sees Ankerberg's extensive experience from the consumer industry as ideal to help commercialize the SiPore® platform in the dietary supplement, oral health and veterinary markets.
Sigrid Therapeutics is a privately held consumer-focused health technology company driven by the vision that no one should suffer from chronic lifestyle diseases such as type 2 diabetes and obesity. Sigrid has developed and patented a unique silicon-based platform technology, SiPore®, that limits the breakdown of food in the gut, thereby lowering blood sugar and blood lipids. SiPore® has the potential to be used in a range of metabolic disorders, and the first product, SiPore21®, has been shown in clinical studies to lower blood sugar (HbA1c), cholesterol and body fat in prediabetics and early-stage type 2 diabetics.
– Sigrid is now entering an exciting phase of commercial development. In addition to our core business, namely the development of a medical device for diabetes prevention, we have identified several other major application areas for our patented technology – including dietary supplements, oral health and veterinary products – and have prepared business plans for each. The experience and knowledge of the consumer and retail sector that Mattias brings will be invaluable in successfully realizing our commercial plans, says Sana Ajamovic, Sigrid's co-founder and CEO.
– I have followed Sigrid's rapid development and am now happy to become part of Sigrid and contribute to its growth through my experience, including driving international expansion, establishing e-commerce and realizing new ideas. I look forward to working with the founders, the board and Sigrid's committed team to bring Sigrid closer to realizing both the vision and what is a clear commercial potential in the short term, adds Mattias Ankarberg.
Topics
Categories
SIGRID is a Swedish consumer health company developing technologies designed to reduce the metabolic impact of modern meals. The company’s patented SiPore® technology works locally in the gastrointestinal tract by interacting with digestive enzymes involved in carbohydrate and fat digestion. By slowing nutrient breakdown during digestion, SiPore® supports steadier post-meal metabolic responses. SIGRID collaborates with clinicians, researchers, and health innovators to translate metabolic science into practical solutions supporting metabolic health, weight management, and glucose stability. The company was founded in 2014 and is headquartered in Stockholm, Sweden.